These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3246714)

  • 1. [Successful treatment of chronic myelomonocytic leukemia (CMMoL) with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PLAC)].
    Ozawa M; Iwamoto K; Kitani K; Mizuno T; Kobayashi Y; Horiuchi H; Maruo N; Kondo M; Horiike S; Misawa S
    Rinsho Ketsueki; 1988 Dec; 29(12):2297-301. PubMed ID: 3246714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment with a small dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in a case of chronic myelomonocytic leukemia in blastic crisis].
    Tsukada J; Misago M; Sato T; Kikuchi M; Nakata K; Nagata K; Mori N; Otani H; Oda S; Chiba S
    Rinsho Ketsueki; 1989 Jan; 30(1):61-6. PubMed ID: 2716200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13), PDGFRB-NDE1 fusion.
    Cavazzini F; Bardi A; Ciccone M; Rigolin GM; Gorello P; La Starza R; Mecucci C; Cuneo A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):67-9. PubMed ID: 19737658
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained response to low-dose imatinib mesylate in a patient with chronic myelomonocytic leukemia with t(5;12)(q33;p13).
    Shin J; Kim M; Kim DB; Yeom JO; Lee HJ; Cho SG
    Acta Haematol; 2008; 119(1):57-9. PubMed ID: 18268406
    [No Abstract]   [Full Text] [Related]  

  • 5. [A phase II study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC].
    Kimura K
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2475-81. PubMed ID: 3619459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells.
    Tsuruo T; Iida H; Hori K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 Nov; 41(11 Pt 1):4484-8. PubMed ID: 7306971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of myelodysplastic syndromes (MDS) with oral administration of N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine (PLAC)].
    Ohno R; Kimura K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1205-8. PubMed ID: 3382195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M; Kantarjian H
    Semin Hematol; 1999 Oct; 36(4 Suppl 8):3-10. PubMed ID: 10622223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
    Schott H; Schwendener RA
    Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypoplastic leukemia--clinical effects of low-dose 4N-behenoyl-beta-D-arabinofuranosylcytosine (BH-AC) therapy].
    Nakada H; Takahashi I; Yorimitu S; Hara M; Ohmoto E; Inagaki T; Aoyama S; Nishimura M; Hayashi N; Sekito N
    Rinsho Ketsueki; 1987 Apr; 28(4):534-40. PubMed ID: 3476764
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme catalyzation of the deacylation of N4-acyl derivatives of 1-beta-D-arabinofuranosylcytosine in the mouse liver microsome.
    Tsuruo T; Hori K; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Jun; 42(6):2250-4. PubMed ID: 7074607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double t (3; 21) in acute myelomonocytic leukemia transformed from chronic myelomonocytic leukemia].
    Arai Y; Handa T; Nakamura F; Takahashi W; Maki K; Mitani K
    Rinsho Ketsueki; 2002 Sep; 43(9):865-7. PubMed ID: 12412294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel interstitial deletion on the long arm of chromosome 16 in a patient with chronic myelomonocytic leukemia.
    Kozon LK; Wesley DL; Van Brunt J; Li MM
    Cancer Genet Cytogenet; 2005 Oct; 162(1):92-4. PubMed ID: 16157209
    [No Abstract]   [Full Text] [Related]  

  • 15. An unusual cytogenetic abnormality involving chromosomes 1 and 7 in a case of chronic myelomonocytic leukemia.
    Papadhimitriou SI; Abazis D; Repa C; Papaconstantinou C; Papanastasiou C; Pangalos C; Stamatelou M
    Cancer Genet Cytogenet; 1995 Nov; 85(1):75-7. PubMed ID: 8536243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
    Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies].
    Takubo T; Kubota Y; Tanaka T; Ueda T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):283-9. PubMed ID: 6576729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel isoderivative chromosome 20 in a patient with chronic myelomonocytic leukemia.
    Lim TH; Lim AS; Tien SL
    Cancer Genet Cytogenet; 2006 Oct; 170(1):80-2. PubMed ID: 16965963
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of juvenile chronic myelocytic leukemia with multidrug chemotherapy including aclacinomycin and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Ishii E; Matsuzaki A; Kato Y; Miyazaki S; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1297-9. PubMed ID: 3468729
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.
    Ueda T; Nakamura T; Kagawa D; Uchida M; Domae N; Sugiyama M; Ueda Y; Sasada M; Uchino H
    Cancer Chemother Pharmacol; 1989; 24(6):371-5. PubMed ID: 2791191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.